MedPath

VITEIA PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

17

TGA:17

Drug Approvals

ON REPEAT (477367)

Product Name
ON REPEAT
Approval Date
Jan 31, 2025
TGA

TOUGH LUXE (473185)

Product Name
TOUGH LUXE
Approval Date
Dec 16, 2024
TGA

Soleil Protect Anti Wrinkle Smoothing Fluid SPF50 (449231)

Product Name
Soleil Protect Anti Wrinkle Smoothing Fluid SPF50
Approval Date
May 21, 2024
TGA

Soleil Protect High Tolerance Comfort Fluid SPF50 (449232)

Product Name
Soleil Protect High Tolerance Comfort Fluid SPF50
Approval Date
May 21, 2024
TGA

Soleil Protect Anti Brown Spot Unifying Fluid SPF50 (449229)

Product Name
Soleil Protect Anti Brown Spot Unifying Fluid SPF50
Approval Date
May 21, 2024
TGA

BLUSH GLOW (443832)

Product Name
BLUSH GLOW
Approval Date
Mar 15, 2024
TGA

PEARL GLOW (443123)

Product Name
PEARL GLOW
Approval Date
Mar 4, 2024
TGA

BRONZE GLOW (443122)

Product Name
BRONZE GLOW
Approval Date
Mar 4, 2024
TGA

ROCAL TABLET 500 mg (370556)

Product Name
ROCAL TABLET 500 mg
Approval Date
Jul 5, 2021
TGA

IRBESARTAN MYLAN irbesartan 300 mg tablet blister pack (214581)

Product Name
IRBESARTAN MYLAN irbesartan 300 mg tablet blister pack
Approval Date
Nov 6, 2013
TGA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.